全球冷凝集素病市場（2022-2028）：按藥物、劑型、最終用戶和地區劃分的市場規模調查和預測

預計 2022-2028 年預測期內，全球冷凝集素市場將以健康的增長率增長。推動市場的主要因素是老年人的增加、冷凝集素的發病率增加、醫療費用的增加。然而，在新興市場，缺乏熟練的專業人員和缺乏醫療基礎設施正在阻礙預測期內的市場增長。此外，預計在預測期內，藥物批准和上市數量的增加以及對先進技術開發投資的擴大將成為市場需求的催化劑。

本報告調查了全球冷凝集素市場、市場概況、市場促進劑/抑製劑分析、市場機會、COVID-19 影響、細分市場分析，它提供了主要公司的競爭狀況和概況等系統信息。

目錄

第 1 章執行摘要

第 2 章全球冷凝集素市場：定義和範圍

第 3 章世界冷凝集症：市場動態

• 冷凝集素市場：影響分析（2020-2028 年）

第 4 章全球冷凝集素市場：行業分析

• 波特五力模型
• PEST 分析
• 投資採用模式
• 分析師建議和結論
• 主要投資機會
• 關鍵成功策略

第 5 章風險評估：COVID-19 的影響

• 評估 COVID-19 對行業的整體影響
• COVID-19 前後的市場情景

第 6 章全球冷凝集素市場：按藥物分類

• 市場快照
• 成就：潛力分析
• 市場規模估計和預測（2018-2028）
• 細分分析
  • 皮質類固醇
  • 烷化劑
  • 嘌呤核甘類似物
  • 生物製藥
  • 其他

第 7 章全球冷凝集素疾病市場：按劑型

• 市場快照
• 成就：潛力分析
• 市場規模估計和預測（2018-2028）
• 細分分析
  • 片劑
  • 注入
  • 其他

第 8 章全球冷凝集素市場：按最終用戶分類

• 市場快照
• 成就：潛力分析
• 市場規模估計和預測（2018-2028）
• 細分分析
  • 醫院
  • 專科門診
  • 家庭醫療
  • 其他

第 9 章全球冷凝集素市場：區域分析

• 區域市場概況
• 北美
  • 美國
  • 加拿大
• 歐洲快照
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 意大利
  • 其他歐洲
• 亞太地區快照
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 其他亞太地區
• 拉丁美洲快照
  • 巴西
  • 墨西哥
• 其他領域

第10章競爭態勢

• 主要市場策略
• 公司簡介
  • Sanofi
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Zydus Cadila
  • AstraZeneca
  • Johnson & Johnson
  • Bayer AG
  • Sun Pharmaceutical Industries Ltd.
  • Apellis Pharmaceuticals

第11章 調查流程

Global Cold Agglutinin Disease Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Cold agglutinin disease (CAD) is a variety of autoimmune hemolytic anemia (AIHA). In this condition, the individual's immune system attacks and destroys their own red blood cells (RBCs) because of the higher exposure to cold temperatures. The increasing number of geriatric people, rising incidences of cold agglutinin disease, and growing healthcare expenditure are major factors fueling the market demand across the globe. For instance, according to the Department of Economic and Social Affairs, in 2019, the world's population of people aged 65 and up totaled 703 million. Also, the number of elderly people is expected to increase to 1.5 billion by 2050. Accordingly, the increasing number of aged people are more likely to suffer from Cold Agglutinin Disease, which, in turn, bolsters the growth of the global market. However, the shortage of skilled professionals and lack of healthcare infrastructure in emerging regions impede the growth of the market over the forecast period of 2022-2028. Also, an increase in the number of drug approvals and launches and growing investment in the development of advanced technologies are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Cold Agglutinin Disease Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the increasing healthcare expenditure, the presence of various prominent market players, and growing investment in R&D activities. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the increasing patient pool, as well as availability of better healthcare facilities, would create lucrative growth prospects for the Cold Agglutinin Disease Market across the Asia-Pacific region.

Major market players included in this report are:

Sanofi

Pfizer Inc.

GlaxoSmithKline plc

Novartis AG

Zydus Cadila

AstraZeneca

Johnson & Johnson

Bayer AG

Sun Pharmaceutical Industries Ltd.

Apellis Pharmaceuticals

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drugs:

Corticosteroids

Alkylating Agents

Purine Nucleoside Analogs

Biologics

Others

By Dosage Form:

Tablets

Injections

Others

By End-Users:

Hospitals

Specialty Clinics

Homecare

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Cold Agglutinin Disease Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
  • 1.2.1. Cold Agglutinin Disease Market, by Region, 2020-2028 (USD Million)
  • 1.2.2. Cold Agglutinin Disease Market, by Drugs, 2020-2028 (USD Million)
  • 1.2.3. Cold Agglutinin Disease Market, by Dosage Form, 2020-2028 (USD Million)
  • 1.2.4. Cold Agglutinin Disease Market, by End-Users, 2020-2028 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Cold Agglutinin Disease Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Cold Agglutinin Disease Market Dynamics

• 3.1. Cold Agglutinin Disease Market Impact Analysis (2020-2028)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing number of geriatric people
    • 3.1.1.2. Rising incidences of cold agglutinin disease
  • 3.1.2. Market Challenges
    • 3.1.2.1. Shortage of skilled professionals
    • 3.1.2.2. Lack of healthcare infrastructure in emerging regions
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increase in number of drug approvals and launches
    • 3.1.3.2. Growing investment in development of advanced technologies

Chapter 4. Global Cold Agglutinin Disease Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
• 4.2. PEST Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
• 4.3. Investment Adoption Model
• 4.4. Analyst Recommendation & Conclusion
• 4.5. Top investment opportunity
• 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1.1. Assessment of the overall impact of COVID-19 on the industry
• 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Cold Agglutinin Disease Market, by Drugs

• 6.1. Market Snapshot
• 6.2. Global Cold Agglutinin Disease Market by Drugs, Performance - Potential Analysis
• 6.3. Global Cold Agglutinin Disease Market Estimates & Forecasts by Drugs, 2018-2028 (USD Million)
• 6.4. Cold Agglutinin Disease Market, Sub Segment Analysis
  • 6.4.1. Corticosteroids
  • 6.4.2. Alkylating Agents
  • 6.4.3. Purine Nucleoside Analogs
  • 6.4.4. Biologics
  • 6.4.5. Others

Chapter 7. Global Cold Agglutinin Disease Market, by Dosage Form

• 7.1. Market Snapshot
• 7.2. Global Cold Agglutinin Disease Market by Dosage form, Performance - Potential Analysis
• 7.3. Global Cold Agglutinin Disease Market Estimates & Forecasts by Dosage form, 2018-2028 (USD Million)
• 7.4. Cold Agglutinin Disease Market, Sub Segment Analysis
  • 7.4.1. Tablets
  • 7.4.2. Injections
  • 7.4.3. Others

Chapter 8. Global Cold Agglutinin Disease Market, by End-Users

• 8.1. Market Snapshot
• 8.2. Global Cold Agglutinin Disease Market by End-Users, Performance - Potential Analysis
• 8.3. Global Cold Agglutinin Disease Market Estimates & Forecasts by End-Users, 2018-2028 (USD Million)
• 8.4. Cold Agglutinin Disease Market, Sub Segment Analysis
  • 8.4.1. Hospitals
  • 8.4.2. Specialty Clinics
  • 8.4.3. Homecare
  • 8.4.4. Others

Chapter 9. Global Cold Agglutinin Disease Market, Regional Analysis

• 9.1. Cold Agglutinin Disease Market, Regional Market Snapshot
• 9.2. North America Cold Agglutinin Disease Market
  • 9.2.1. U.S. Cold Agglutinin Disease Market
    • 9.2.1.1. Drugs breakdown estimates & forecasts, 2018-2028
    • 9.2.1.2. Dosage form breakdown estimates & forecasts, 2018-2028
    • 9.2.1.3. End-Users breakdown estimates & forecasts, 2018-2028
  • 9.2.2. Canada Cold Agglutinin Disease Market
• 9.3. Europe Cold Agglutinin Disease Market Snapshot
  • 9.3.1. U.K. Cold Agglutinin Disease Market
  • 9.3.2. Germany Cold Agglutinin Disease Market
  • 9.3.3. France Cold Agglutinin Disease Market
  • 9.3.4. Spain Cold Agglutinin Disease Market
  • 9.3.5. Italy Cold Agglutinin Disease Market
  • 9.3.6. Rest of Europe Cold Agglutinin Disease Market
• 9.4. Asia-Pacific Cold Agglutinin Disease Market Snapshot
  • 9.4.1. China Cold Agglutinin Disease Market
  • 9.4.2. India Cold Agglutinin Disease Market
  • 9.4.3. Japan Cold Agglutinin Disease Market
  • 9.4.4. Australia Cold Agglutinin Disease Market
  • 9.4.5. South Korea Cold Agglutinin Disease Market
  • 9.4.6. Rest of Asia Pacific Cold Agglutinin Disease Market
• 9.5. Latin America Cold Agglutinin Disease Market Snapshot
  • 9.5.1. Brazil Cold Agglutinin Disease Market
  • 9.5.2. Mexico Cold Agglutinin Disease Market
• 9.6. Rest of The World Cold Agglutinin Disease Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Sanofi
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Pfizer Inc.
  • 10.2.3. GlaxoSmithKline plc
  • 10.2.4. Novartis AG
  • 10.2.5. Zydus Cadila
  • 10.2.6. AstraZeneca
  • 10.2.7. Johnson & Johnson
  • 10.2.8. Bayer AG
  • 10.2.9. Sun Pharmaceutical Industries Ltd.
  • 10.2.10. Apellis Pharmaceuticals

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Cold Agglutinin Disease Market, report scope
• TABLE 2. Global Cold Agglutinin Disease Market estimates & forecasts by Region 2018-2028 (USD Million)
• TABLE 3. Global Cold Agglutinin Disease Market estimates & forecasts by Drugs 2018-2028 (USD Million)
• TABLE 4. Global Cold Agglutinin Disease Market estimates & forecasts by Dosage form 2018-2028 (USD Million)
• TABLE 5. Global Cold Agglutinin Disease Market estimates & forecasts by End-Users 2018-2028 (USD Million)
• TABLE 6. Global Cold Agglutinin Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 7. Global Cold Agglutinin Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 8. Global Cold Agglutinin Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 9. Global Cold Agglutinin Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 10. Global Cold Agglutinin Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 11. Global Cold Agglutinin Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 12. Global Cold Agglutinin Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 13. Global Cold Agglutinin Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 14. Global Cold Agglutinin Disease Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 15. Global Cold Agglutinin Disease Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 16. U.S. Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 17. U.S. Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 18. U.S. Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 19. Canada Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 20. Canada Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 21. Canada Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 22. UK Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 23. UK Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 24. UK Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 25. Germany Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 26. Germany Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 27. Germany Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 28. RoE Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 29. RoE Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 30. RoE Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 31. China Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 32. China Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 33. China Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 34. India Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 35. India Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 36. India Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 37. Japan Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 38. Japan Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 39. Japan Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 40. RoAPAC Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 41. RoAPAC Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 42. RoAPAC Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 43. Brazil Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 44. Brazil Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 45. Brazil Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 46. Mexico Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 47. Mexico Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 48. Mexico Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 49. RoLA Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 50. RoLA Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 51. RoLA Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 52. Row Cold Agglutinin Disease Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 53. Row Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 54. Row Cold Agglutinin Disease Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 55. List of secondary sources, used in the study of global Cold Agglutinin Disease Market
• TABLE 56. List of primary sources, used in the study of global Cold Agglutinin Disease Market
• TABLE 57. Years considered for the study
• TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

• FIG 1. Global Cold Agglutinin Disease Market, research methodology
• FIG 2. Global Cold Agglutinin Disease Market, market estimation techniques
• FIG 3. Global market size estimates & forecast methods
• FIG 4. Global Cold Agglutinin Disease Market, key trends 2021
• FIG 5. Global Cold Agglutinin Disease Market, growth prospects 2022-2028
• FIG 6. Global Cold Agglutinin Disease Market, porters 5 force model
• FIG 7. Global Cold Agglutinin Disease Market, pest analysis
• FIG 8. Global Cold Agglutinin Disease Market, value chain analysis
• FIG 9. Global Cold Agglutinin Disease Market by segment, 2018 & 2028 (USD Million)
• FIG 10. Global Cold Agglutinin Disease Market by segment, 2018 & 2028 (USD Million)
• FIG 11. Global Cold Agglutinin Disease Market by segment, 2018 & 2028 (USD Million)
• FIG 12. Global Cold Agglutinin Disease Market by segment, 2018 & 2028 (USD Million)
• FIG 13. Global Cold Agglutinin Disease Market by segment, 2018 & 2028 (USD Million)
• FIG 14. Global Cold Agglutinin Disease Market, regional snapshot 2018 & 2028
• FIG 15. North America Cold Agglutinin Disease Market 2018 & 2028 (USD Million)
• FIG 16. Europe Cold Agglutinin Disease Market 2018 & 2028 (USD Million)
• FIG 17. Asia Pacific Cold Agglutinin Disease market 2018 & 2028 (USD Million)
• FIG 18. Latin America Cold Agglutinin Disease Market 2018 & 2028 (USD Million)
• FIG 19. Global Cold Agglutinin Disease Market, company market share analysis (2021)